

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | B cell receptor signaling pathway (GO:0050853) | 9.84067357 |
| 2 | antigen processing and presentation of endogenous antigen (GO:0019883) | 8.82057615 |
| 3 | myeloid dendritic cell differentiation (GO:0043011) | 8.02804415 |
| 4 | cellular response to zinc ion (GO:0071294) | 7.55271733 |
| 5 | myeloid dendritic cell activation (GO:0001773) | 7.09444213 |
| 6 | positive regulation of gamma-delta T cell activation (GO:0046645) | 7.05666697 |
| 7 | regulation of B cell differentiation (GO:0045577) | 6.40721326 |
| 8 | apoptotic cell clearance (GO:0043277) | 6.14144857 |
| 9 | positive thymic T cell selection (GO:0045059) | 6.08864384 |
| 10 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.87458919 |
| 11 | Golgi transport vesicle coating (GO:0048200) | 5.75381462 |
| 12 | COPI coating of Golgi vesicle (GO:0048205) | 5.75381462 |
| 13 | hepatocyte apoptotic process (GO:0097284) | 5.66542975 |
| 14 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.61621515 |
| 15 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.61621515 |
| 16 | cellular extravasation (GO:0045123) | 5.59550128 |
| 17 | regulation of gamma-delta T cell differentiation (GO:0045586) | 5.57418899 |
| 18 | B cell proliferation (GO:0042100) | 5.42599311 |
| 19 | positive regulation of B cell differentiation (GO:0045579) | 5.42563180 |
| 20 | mature B cell differentiation (GO:0002335) | 5.28393902 |
| 21 | regulation of gamma-delta T cell activation (GO:0046643) | 5.03573541 |
| 22 | dendritic cell differentiation (GO:0097028) | 5.00272563 |
| 23 | negative regulation of bone remodeling (GO:0046851) | 4.96964046 |
| 24 | negative regulation of B cell proliferation (GO:0030889) | 4.84698299 |
| 25 | positive regulation of Rap GTPase activity (GO:0032854) | 4.81943700 |
| 26 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 4.73529406 |
| 27 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.71294853 |
| 28 | regulation of B cell proliferation (GO:0030888) | 4.66032550 |
| 29 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 4.64638240 |
| 30 | cellular response to interleukin-15 (GO:0071350) | 4.63351181 |
| 31 | antigen receptor-mediated signaling pathway (GO:0050851) | 4.57277883 |
| 32 | negative regulation of histone methylation (GO:0031061) | 4.54455801 |
| 33 | response to interleukin-15 (GO:0070672) | 4.54208206 |
| 34 | regulation of alpha-beta T cell proliferation (GO:0046640) | 4.48982153 |
| 35 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 4.47332575 |
| 36 | response to hydroperoxide (GO:0033194) | 4.41750355 |
| 37 | positive T cell selection (GO:0043368) | 4.34193328 |
| 38 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 4.31846723 |
| 39 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.30171283 |
| 40 | thymic T cell selection (GO:0045061) | 4.29383451 |
| 41 | defense response to protozoan (GO:0042832) | 4.29305274 |
| 42 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 4.27719979 |
| 43 | mannose metabolic process (GO:0006013) | 4.27433554 |
| 44 | negative thymic T cell selection (GO:0045060) | 4.24975341 |
| 45 | negative regulation of fibroblast apoptotic process (GO:2000270) | 4.24257650 |
| 46 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 4.22549360 |
| 47 | T cell migration (GO:0072678) | 4.21698599 |
| 48 | regulation of B cell apoptotic process (GO:0002902) | 4.21178837 |
| 49 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 4.20721691 |
| 50 | negative regulation of humoral immune response (GO:0002921) | 4.18590836 |
| 51 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 4.14133725 |
| 52 | positive regulation of nuclease activity (GO:0032075) | 4.12033472 |
| 53 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.10751181 |
| 54 | complement activation, classical pathway (GO:0006958) | 4.08573590 |
| 55 | lymph node development (GO:0048535) | 4.08032703 |
| 56 | negative regulation of tissue remodeling (GO:0034104) | 4.06276160 |
| 57 | regulation of Rap GTPase activity (GO:0032317) | 4.04982529 |
| 58 | protein retention in ER lumen (GO:0006621) | 4.02832978 |
| 59 | protein N-linked glycosylation via asparagine (GO:0018279) | 4.02276063 |
| 60 | T cell selection (GO:0045058) | 4.00678228 |
| 61 | peptidyl-asparagine modification (GO:0018196) | 3.98462448 |
| 62 | positive regulation of B cell proliferation (GO:0030890) | 3.94001036 |
| 63 | long term synaptic depression (GO:0060292) | 3.91645709 |
| 64 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 3.91409637 |
| 65 | negative T cell selection (GO:0043383) | 3.88470010 |
| 66 | NIK/NF-kappaB signaling (GO:0038061) | 3.86164706 |
| 67 | B cell activation (GO:0042113) | 3.82773353 |
| 68 | signal peptide processing (GO:0006465) | 3.80775181 |
| 69 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 3.78234915 |
| 70 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.77929532 |
| 71 | regulation of nuclease activity (GO:0032069) | 3.77078528 |
| 72 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.74877612 |
| 73 | negative regulation of B cell apoptotic process (GO:0002903) | 3.74186068 |
| 74 | immunoglobulin mediated immune response (GO:0016064) | 3.74052162 |
| 75 | protein targeting to ER (GO:0045047) | 3.70494724 |
| 76 | B cell homeostasis (GO:0001782) | 3.70300115 |
| 77 | protein N-linked glycosylation (GO:0006487) | 3.69984185 |
| 78 | mature B cell differentiation involved in immune response (GO:0002313) | 3.69712323 |
| 79 | cotranslational protein targeting to membrane (GO:0006613) | 3.69431018 |
| 80 | response to endoplasmic reticulum stress (GO:0034976) | 3.65618586 |
| 81 | mast cell activation (GO:0045576) | 3.62920629 |
| 82 | regulation of superoxide anion generation (GO:0032928) | 3.62463702 |
| 83 | positive regulation of histone deacetylation (GO:0031065) | 3.62223678 |
| 84 | positive regulation of antigen processing and presentation (GO:0002579) | 3.60714213 |
| 85 | endoplasmic reticulum unfolded protein response (GO:0030968) | 3.59530662 |
| 86 | positive regulation of immunoglobulin production (GO:0002639) | 3.57639422 |
| 87 | lymphocyte homeostasis (GO:0002260) | 3.57059086 |
| 88 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.57008367 |
| 89 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.56198686 |
| 90 | response to protozoan (GO:0001562) | 3.52078848 |
| 91 | cellular response to unfolded protein (GO:0034620) | 3.50903837 |
| 92 | response to interferon-alpha (GO:0035455) | 3.48832773 |
| 93 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.47313541 |
| 94 | germinal center formation (GO:0002467) | 3.47106705 |
| 95 | mast cell activation involved in immune response (GO:0002279) | 3.46881731 |
| 96 | mast cell degranulation (GO:0043303) | 3.46881731 |
| 97 | negative regulation of phagocytosis (GO:0050765) | 3.46638200 |
| 98 | positive regulation of interferon-alpha production (GO:0032727) | 3.46626783 |
| 99 | positive regulation of B cell activation (GO:0050871) | 3.44997469 |
| 100 | positive regulation of interleukin-2 production (GO:0032743) | 3.44102545 |
| 101 | regulation of B cell activation (GO:0050864) | 3.44069306 |
| 102 | T cell homeostasis (GO:0043029) | 3.43707618 |
| 103 | protein localization to endoplasmic reticulum (GO:0070972) | 3.42989507 |
| 104 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 3.41920604 |
| 105 | mitochondrion distribution (GO:0048311) | 3.41063164 |
| 106 | negative regulation of cell killing (GO:0031342) | 3.40643002 |
| 107 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.40643002 |
| 108 | respiratory burst (GO:0045730) | 3.37242641 |
| 109 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.36625315 |
| 110 | cellular response to antibiotic (GO:0071236) | 3.34724225 |
| 111 | T cell costimulation (GO:0031295) | 3.33915120 |
| 112 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.33510093 |
| 113 | cell redox homeostasis (GO:0045454) | 3.32027742 |
| 114 | regulation of fibroblast apoptotic process (GO:2000269) | 3.29396115 |
| 115 | regulation of interferon-alpha production (GO:0032647) | 3.27318999 |
| 116 | activation of JUN kinase activity (GO:0007257) | 3.26099122 |
| 117 | lymphocyte costimulation (GO:0031294) | 3.25809328 |
| 118 | ER-nucleus signaling pathway (GO:0006984) | 3.23171697 |
| 119 | cellular response to topologically incorrect protein (GO:0035967) | 3.21588908 |
| 120 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 3.18452000 |
| 121 | modulation by virus of host process (GO:0019054) | 3.18116413 |
| 122 | regulation of triglyceride catabolic process (GO:0010896) | 3.17417732 |
| 123 | regulation of MHC class I biosynthetic process (GO:0045343) | 3.14027342 |
| 124 | mononuclear cell proliferation (GO:0032943) | 3.12975493 |
| 125 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 3.12186729 |
| 126 | lymphocyte proliferation (GO:0046651) | 3.11916823 |
| 127 | negative regulation of alpha-beta T cell activation (GO:0046636) | 3.10899382 |
| 128 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.10182661 |
| 129 | cellular response to type I interferon (GO:0071357) | 3.10004557 |
| 130 | type I interferon signaling pathway (GO:0060337) | 3.10004557 |
| 131 | N-terminal protein amino acid acetylation (GO:0006474) | 3.09310270 |
| 132 | complement activation (GO:0006956) | 3.09273119 |
| 133 | leukocyte homeostasis (GO:0001776) | 3.08585342 |
| 134 | negative regulation of bone resorption (GO:0045779) | 3.07736855 |
| 135 | cellular hyperosmotic response (GO:0071474) | 3.06951045 |
| 136 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.05886361 |
| 137 | response to type I interferon (GO:0034340) | 3.05600564 |
| 138 | positive regulation of macrophage cytokine production (GO:0060907) | 3.05232637 |
| 139 | regulation of histone H3-K9 methylation (GO:0051570) | 3.05162214 |
| 140 | B cell differentiation (GO:0030183) | 3.04291994 |
| 141 | Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096) | 3.02096817 |
| 142 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis (GO:0002 | 3.02096817 |
| 143 | Fc-gamma receptor signaling pathway (GO:0038094) | 3.02096817 |
| 144 | I-kappaB phosphorylation (GO:0007252) | 2.99337661 |
| 145 | phagocytosis (GO:0006909) | 2.99083824 |
| 146 | response to laminar fluid shear stress (GO:0034616) | 2.97830299 |
| 147 | Fc receptor mediated stimulatory signaling pathway (GO:0002431) | 2.97150141 |
| 148 | modulation by symbiont of host cellular process (GO:0044068) | 2.94644659 |
| 149 | regulation of antigen processing and presentation (GO:0002577) | 2.93943079 |
| 150 | negative regulation of nitric-oxide synthase activity (GO:0051001) | 2.93682828 |
| 151 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.93517017 |
| 152 | viral transcription (GO:0019083) | 2.93152841 |
| 153 | lymphocyte chemotaxis (GO:0048247) | 2.93048901 |
| 154 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.92770491 |
| 155 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.92233421 |
| 156 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.92048926 |
| 157 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.91257164 |
| 158 | immune response-activating signal transduction (GO:0002757) | 2.90974922 |
| 159 | regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664) | 2.90292047 |
| 160 | histone H3-K36 demethylation (GO:0070544) | 2.88503197 |
| 161 | tolerance induction (GO:0002507) | 2.88128991 |
| 162 | myeloid leukocyte activation (GO:0002274) | 2.87387477 |
| 163 | positive regulation of cell adhesion mediated by integrin (GO:0033630) | 2.86788549 |
| 164 | negative regulation of mast cell activation (GO:0033004) | 2.86750927 |
| 165 | response to muramyl dipeptide (GO:0032495) | 2.85332930 |
| 166 | mitochondrial calcium ion transport (GO:0006851) | 2.85327298 |
| 167 | positive regulation of granulocyte differentiation (GO:0030854) | 2.84413405 |
| 168 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.83709961 |
| 169 | cellular response to exogenous dsRNA (GO:0071360) | 2.82757441 |
| 170 | serine transport (GO:0032329) | 2.81582802 |
| 171 | peptidyl-proline hydroxylation (GO:0019511) | 2.81135856 |
| 172 | negative regulation of complement activation (GO:0045916) | 2.80866036 |
| 173 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.75731468 |
| 174 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.75495413 |
| 175 | mRNA modification (GO:0016556) | 2.72862154 |
| 176 | T cell proliferation (GO:0042098) | 2.72739379 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 7.38524750 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.37766513 |
| 3 | MYC_22102868_ChIP-Seq_BL_Human | 5.13789632 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.54307367 |
| 5 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 4.09948175 |
| 6 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.64947863 |
| 7 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.64689950 |
| 8 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.56407306 |
| 9 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 3.25119785 |
| 10 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.18118425 |
| 11 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 3.06589023 |
| 12 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.06576760 |
| 13 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.99850659 |
| 14 | MAF_26560356_Chip-Seq_TH1_Human | 2.72057938 |
| 15 | MYB_26560356_Chip-Seq_TH1_Human | 2.67973107 |
| 16 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.56371895 |
| 17 | MYB_26560356_Chip-Seq_TH2_Human | 2.56173024 |
| 18 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.54339342 |
| 19 | UTX_26944678_Chip-Seq_JUKART_Human | 2.49197347 |
| 20 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.36424348 |
| 21 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.35876816 |
| 22 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.33004146 |
| 23 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.29344151 |
| 24 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.28142370 |
| 25 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.26948496 |
| 26 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.24836695 |
| 27 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.23403040 |
| 28 | CIITA_25753668_ChIP-Seq_RAJI_Human | 2.22235558 |
| 29 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.20212406 |
| 30 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.15755622 |
| 31 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.09246740 |
| 32 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.00009566 |
| 33 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.99154086 |
| 34 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.93490915 |
| 35 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.85317078 |
| 36 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.84042404 |
| 37 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.82849901 |
| 38 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.81091968 |
| 39 | MAF_26560356_Chip-Seq_TH2_Human | 1.79754612 |
| 40 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.79634391 |
| 41 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.78991100 |
| 42 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.75855130 |
| 43 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.73520867 |
| 44 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.71234088 |
| 45 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.70347826 |
| 46 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.70129630 |
| 47 | GATA1_22025678_ChIP-Seq_K562_Human | 1.67700334 |
| 48 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.67381890 |
| 49 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.60163426 |
| 50 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.59750518 |
| 51 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.59253633 |
| 52 | SPI1_23127762_ChIP-Seq_K562_Human | 1.58623194 |
| 53 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.58449149 |
| 54 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.52919101 |
| 55 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.43022540 |
| 56 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.41238956 |
| 57 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.41101298 |
| 58 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.36407383 |
| 59 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.36340280 |
| 60 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.30194281 |
| 61 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.30185978 |
| 62 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.29941305 |
| 63 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.27503290 |
| 64 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.27202315 |
| 65 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.26574292 |
| 66 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.26134486 |
| 67 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.25235524 |
| 68 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.24967610 |
| 69 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.24758555 |
| 70 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.21825945 |
| 71 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.20920234 |
| 72 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.20598958 |
| 73 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.19256010 |
| 74 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.18775656 |
| 75 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.17788921 |
| 76 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.16991450 |
| 77 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.16273772 |
| 78 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.15751624 |
| 79 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.15288619 |
| 80 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.14961694 |
| 81 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.13430124 |
| 82 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.11617390 |
| 83 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.09083812 |
| 84 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.08984655 |
| 85 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.08800796 |
| 86 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.06845212 |
| 87 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.05858812 |
| 88 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.03776734 |
| 89 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.02313581 |
| 90 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.00845356 |
| 91 | GATA3_26560356_Chip-Seq_TH2_Human | 1.00225914 |
| 92 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.99954009 |
| 93 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 0.98813013 |
| 94 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.97852187 |
| 95 | DCP1A_22483619_ChIP-Seq_HELA_Human | 0.97698745 |
| 96 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.97093168 |
| 97 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.96680480 |
| 98 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.96559045 |
| 99 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.93701226 |
| 100 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92520970 |
| 101 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.92241429 |
| 102 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.91877900 |
| 103 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 0.91798163 |
| 104 | CHD1_26751641_Chip-Seq_LNCaP_Human | 0.91497162 |
| 105 | P300_27268052_Chip-Seq_Bcells_Human | 0.91049761 |
| 106 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.89044788 |
| 107 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.88296312 |
| 108 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.87856616 |
| 109 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.87375602 |
| 110 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.86522329 |
| 111 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.86471056 |
| 112 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.85969821 |
| 113 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.83445040 |
| 114 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.82878250 |
| 115 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.81268919 |
| 116 | E2F7_22180533_ChIP-Seq_HELA_Human | 0.80361299 |
| 117 | GATA3_26560356_Chip-Seq_TH1_Human | 0.79961929 |
| 118 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.79579394 |
| 119 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.79143044 |
| 120 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.78796022 |
| 121 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.77193285 |
| 122 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.76812136 |
| 123 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.76421587 |
| 124 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.75626566 |
| 125 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.75087021 |
| 126 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.75050463 |
| 127 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.73407785 |
| 128 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.72335521 |
| 129 | FLI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.70067884 |
| 130 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.69922127 |
| 131 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.69853569 |
| 132 | GATA1_19941826_ChIP-Seq_K562_Human | 0.68800070 |
| 133 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.67621926 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 6.08142333 |
| 2 | * MP0005387_immune_system_phenotype | 5.37568530 |
| 3 | * MP0001790_abnormal_immune_system | 5.37568530 |
| 4 | * MP0001800_abnormal_humoral_immune | 5.25420251 |
| 5 | * MP0002452_abnormal_antigen_presenting | 3.88009129 |
| 6 | MP0003303_peritoneal_inflammation | 3.70286742 |
| 7 | MP0000685_abnormal_immune_system | 3.59069626 |
| 8 | MP0005000_abnormal_immune_tolerance | 3.52819806 |
| 9 | MP0004264_abnormal_extraembryonic_tissu | 3.29391125 |
| 10 | * MP0002723_abnormal_immune_serum | 3.17510353 |
| 11 | * MP0002420_abnormal_adaptive_immunity | 3.11306171 |
| 12 | MP0005671_abnormal_response_to | 3.08399223 |
| 13 | * MP0001819_abnormal_immune_cell | 2.99916656 |
| 14 | MP0002398_abnormal_bone_marrow | 2.92464481 |
| 15 | * MP0000716_abnormal_immune_system | 2.70144344 |
| 16 | MP0000689_abnormal_spleen_morphology | 2.67965124 |
| 17 | MP0004510_myositis | 2.43200360 |
| 18 | MP0003763_abnormal_thymus_physiology | 2.37225626 |
| 19 | MP0005058_abnormal_lysosome_morphology | 2.21293434 |
| 20 | * MP0002429_abnormal_blood_cell | 2.16269517 |
| 21 | MP0002722_abnormal_immune_system | 2.15279240 |
| 22 | MP0003300_gastrointestinal_ulcer | 2.08671436 |
| 23 | MP0001873_stomach_inflammation | 2.07779771 |
| 24 | MP0002419_abnormal_innate_immunity | 2.05354796 |
| 25 | MP0002148_abnormal_hypersensitivity_rea | 2.04622569 |
| 26 | MP0005025_abnormal_response_to | 2.02451349 |
| 27 | MP0005220_abnormal_exocrine_pancreas | 2.01679620 |
| 28 | MP0004084_abnormal_cardiac_muscle | 1.99855196 |
| 29 | MP0003183_abnormal_peptide_metabolism | 1.86415939 |
| 30 | MP0010307_abnormal_tumor_latency | 1.85899758 |
| 31 | MP0003252_abnormal_bile_duct | 1.80468222 |
| 32 | MP0001845_abnormal_inflammatory_respons | 1.74615794 |
| 33 | MP0009785_altered_susceptibility_to | 1.73952246 |
| 34 | MP0001270_distended_abdomen | 1.73221189 |
| 35 | MP0003136_yellow_coat_color | 1.72844160 |
| 36 | MP0001853_heart_inflammation | 1.69552851 |
| 37 | MP0002396_abnormal_hematopoietic_system | 1.69319469 |
| 38 | MP0002166_altered_tumor_susceptibility | 1.69162657 |
| 39 | MP0002405_respiratory_system_inflammati | 1.65959875 |
| 40 | MP0003436_decreased_susceptibility_to | 1.64485327 |
| 41 | MP0005451_abnormal_body_composition | 1.62201321 |
| 42 | MP0004808_abnormal_hematopoietic_stem | 1.59296140 |
| 43 | MP0002909_abnormal_adrenal_gland | 1.53480465 |
| 44 | MP0010155_abnormal_intestine_physiology | 1.52360857 |
| 45 | MP0005171_absent_coat_pigmentation | 1.46325012 |
| 46 | MP0000703_abnormal_thymus_morphology | 1.41592495 |
| 47 | MP0005310_abnormal_salivary_gland | 1.38917814 |
| 48 | MP0010234_abnormal_vibrissa_follicle | 1.34487610 |
| 49 | MP0004947_skin_inflammation | 1.32434604 |
| 50 | MP0008995_early_reproductive_senescence | 1.27822248 |
| 51 | MP0009333_abnormal_splenocyte_physiolog | 1.27181291 |
| 52 | MP0003091_abnormal_cell_migration | 1.26730788 |
| 53 | MP0005464_abnormal_platelet_physiology | 1.26456233 |
| 54 | MP0003866_abnormal_defecation | 1.25537778 |
| 55 | MP0000465_gastrointestinal_hemorrhage | 1.24394947 |
| 56 | MP0002933_joint_inflammation | 1.24213440 |
| 57 | MP0000858_altered_metastatic_potential | 1.19401627 |
| 58 | MP0002876_abnormal_thyroid_physiology | 1.15133023 |
| 59 | MP0004036_abnormal_muscle_relaxation | 1.14997879 |
| 60 | MP0008057_abnormal_DNA_replication | 1.13932700 |
| 61 | MP0002136_abnormal_kidney_physiology | 1.12319111 |
| 62 | MP0004782_abnormal_surfactant_physiolog | 1.09409605 |
| 63 | MP0008961_abnormal_basal_metabolism | 1.08727083 |
| 64 | MP0003045_fibrosis | 1.05425485 |
| 65 | MP0002006_tumorigenesis | 1.03289591 |
| 66 | MP0003693_abnormal_embryo_hatching | 1.01741378 |
| 67 | MP0003787_abnormal_imprinting | 0.97636162 |
| 68 | MP0008874_decreased_physiological_sensi | 0.97582459 |
| 69 | MP0008469_abnormal_protein_level | 0.97105425 |
| 70 | MP0001764_abnormal_homeostasis | 0.96874067 |
| 71 | MP0005174_abnormal_tail_pigmentation | 0.95775041 |
| 72 | MP0002928_abnormal_bile_duct | 0.94985621 |
| 73 | MP0001879_abnormal_lymphatic_vessel | 0.92114402 |
| 74 | MP0000681_abnormal_thyroid_gland | 0.91778651 |
| 75 | MP0003191_abnormal_cellular_cholesterol | 0.91700172 |
| 76 | MP0003890_abnormal_embryonic-extraembry | 0.91318797 |
| 77 | MP0002138_abnormal_hepatobiliary_system | 0.90653870 |
| 78 | MP0003566_abnormal_cell_adhesion | 0.87353714 |
| 79 | MP0001944_abnormal_pancreas_morphology | 0.86660771 |
| 80 | MP0001919_abnormal_reproductive_system | 0.86605901 |
| 81 | MP0000569_abnormal_digit_pigmentation | 0.86541279 |
| 82 | MP0000313_abnormal_cell_death | 0.85399305 |
| 83 | MP0002019_abnormal_tumor_incidence | 0.84142750 |
| 84 | MP0010352_gastrointestinal_tract_polyps | 0.83767790 |
| 85 | MP0008260_abnormal_autophagy | 0.83613044 |
| 86 | MP0003724_increased_susceptibility_to | 0.83131465 |
| 87 | MP0005503_abnormal_tendon_morphology | 0.82937147 |
| 88 | MP0003656_abnormal_erythrocyte_physiolo | 0.82679195 |
| 89 | MP0002168_other_aberrant_phenotype | 0.81195525 |
| 90 | MP0003786_premature_aging | 0.75474471 |
| 91 | MP0005390_skeleton_phenotype | 0.74367019 |
| 92 | MP0001851_eye_inflammation | 0.73466628 |
| 93 | MP0004883_abnormal_blood_vessel | 0.71695673 |
| 94 | MP0003221_abnormal_cardiomyocyte_apopto | 0.68328377 |
| 95 | MP0000767_abnormal_smooth_muscle | 0.68307946 |
| 96 | MP0006054_spinal_hemorrhage | 0.67627845 |
| 97 | MP0000598_abnormal_liver_morphology | 0.66920955 |
| 98 | MP0003279_aneurysm | 0.66070880 |
| 99 | MP0001986_abnormal_taste_sensitivity | 0.65816001 |
| 100 | MP0003943_abnormal_hepatobiliary_system | 0.65593636 |
| 101 | MP0009278_abnormal_bone_marrow | 0.65149618 |
| 102 | MP0000249_abnormal_blood_vessel | 0.63136894 |
| 103 | MP0003077_abnormal_cell_cycle | 0.61941344 |
| 104 | MP0004134_abnormal_chest_morphology | 0.61842966 |
| 105 | MP0005621_abnormal_cell_physiology | 0.61701370 |
| 106 | MP0005076_abnormal_cell_differentiation | 0.59757839 |
| 107 | MP0005408_hypopigmentation | 0.57415580 |
| 108 | MP0003453_abnormal_keratinocyte_physiol | 0.55217873 |
| 109 | MP0001663_abnormal_digestive_system | 0.54934252 |
| 110 | MP0009840_abnormal_foam_cell | 0.54864010 |
| 111 | MP0000613_abnormal_salivary_gland | 0.52855164 |
| 112 | MP0009764_decreased_sensitivity_to | 0.51659081 |
| 113 | MP0008569_lethality_at_weaning | 0.51151812 |
| 114 | MP0002078_abnormal_glucose_homeostasis | 0.51147945 |
| 115 | MP0006082_CNS_inflammation | 0.50713939 |
| 116 | MP0000609_abnormal_liver_physiology | 0.50120503 |
| 117 | MP0000350_abnormal_cell_proliferation | 0.49849254 |
| 118 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.49405004 |
| 119 | MP0000604_amyloidosis | 0.49398709 |
| 120 | MP0002095_abnormal_skin_pigmentation | 0.48797294 |
| 121 | MP0002254_reproductive_system_inflammat | 0.48691585 |
| 122 | MP0000733_abnormal_muscle_development | 0.47578835 |
| 123 | MP0005397_hematopoietic_system_phenotyp | 0.46277166 |
| 124 | MP0001545_abnormal_hematopoietic_system | 0.46277166 |
| 125 | MP0000371_diluted_coat_color | 0.45441475 |
| 126 | MP0000490_abnormal_crypts_of | 0.44799057 |
| 127 | MP0003172_abnormal_lysosome_physiology | 0.43833732 |
| 128 | MP0003828_pulmonary_edema | 0.43403808 |
| 129 | MP0001533_abnormal_skeleton_physiology | 0.43083635 |
| 130 | MP0002135_abnormal_kidney_morphology | 0.43053349 |
| 131 | MP0000015_abnormal_ear_pigmentation | 0.42359783 |
| 132 | MP0001784_abnormal_fluid_regulation | 0.41895281 |
| 133 | MP0010630_abnormal_cardiac_muscle | 0.41730451 |
| 134 | MP0002009_preneoplasia | 0.41303264 |
| 135 | MP0002693_abnormal_pancreas_physiology | 0.40083445 |
| 136 | MP0005023_abnormal_wound_healing | 0.39427078 |
| 137 | MP0002083_premature_death | 0.38423593 |
| 138 | MP0005384_cellular_phenotype | 0.37270424 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Agammaglobulinemia (HP:0004432) | 9.98819305 |
| 2 | Gastrointestinal stroma tumor (HP:0100723) | 8.13083557 |
| 3 | Recurrent bronchitis (HP:0002837) | 6.79951665 |
| 4 | Colitis (HP:0002583) | 6.34919819 |
| 5 | Recurrent sinusitis (HP:0011108) | 6.29543070 |
| 6 | Cellulitis (HP:0100658) | 5.86985577 |
| 7 | Verrucae (HP:0200043) | 5.38004185 |
| 8 | Papilloma (HP:0012740) | 5.38004185 |
| 9 | Inflammation of the large intestine (HP:0002037) | 5.31060616 |
| 10 | Gastrointestinal inflammation (HP:0004386) | 5.09516037 |
| 11 | Emphysema (HP:0002097) | 5.02899695 |
| 12 | Lymphopenia (HP:0001888) | 4.96452281 |
| 13 | IgM deficiency (HP:0002850) | 4.92691072 |
| 14 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.92688015 |
| 15 | Panhypogammaglobulinemia (HP:0003139) | 4.77782275 |
| 16 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 4.68024743 |
| 17 | Recurrent viral infections (HP:0004429) | 4.52668028 |
| 18 | Small epiphyses (HP:0010585) | 4.52497229 |
| 19 | Chronic sinusitis (HP:0011109) | 4.40305551 |
| 20 | Mitral stenosis (HP:0001718) | 4.34803083 |
| 21 | Meningitis (HP:0001287) | 4.30864206 |
| 22 | Chronic otitis media (HP:0000389) | 4.19435550 |
| 23 | Bronchitis (HP:0012387) | 3.92788676 |
| 24 | Recurrent otitis media (HP:0000403) | 3.92589885 |
| 25 | Restrictive lung disease (HP:0002091) | 3.90300106 |
| 26 | Vasculitis (HP:0002633) | 3.88583662 |
| 27 | Osteomyelitis (HP:0002754) | 3.58240681 |
| 28 | Recurrent cutaneous fungal infections (HP:0011370) | 3.57195842 |
| 29 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.57195842 |
| 30 | Vertebral arch anomaly (HP:0008438) | 3.50550822 |
| 31 | Hypercortisolism (HP:0001578) | 3.48164562 |
| 32 | Abnormality of macrophages (HP:0004311) | 3.44405618 |
| 33 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 3.39925887 |
| 34 | Viral hepatitis (HP:0006562) | 3.35509709 |
| 35 | Recurrent abscess formation (HP:0002722) | 3.31844605 |
| 36 | Recurrent bacterial skin infections (HP:0005406) | 3.30067757 |
| 37 | Abnormality of the fingertips (HP:0001211) | 3.26598035 |
| 38 | Recurrent lower respiratory tract infections (HP:0002783) | 3.21823055 |
| 39 | Recurrent pneumonia (HP:0006532) | 3.21253855 |
| 40 | Lower limb hyperreflexia (HP:0002395) | 3.15300625 |
| 41 | Recurrent fungal infections (HP:0002841) | 3.15132501 |
| 42 | Homocystinuria (HP:0002156) | 3.14370507 |
| 43 | Abnormality of homocysteine metabolism (HP:0010919) | 3.14370507 |
| 44 | IgA deficiency (HP:0002720) | 3.13184653 |
| 45 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.08906975 |
| 46 | Mediastinal lymphadenopathy (HP:0100721) | 3.02891613 |
| 47 | Sepsis (HP:0100806) | 2.99978586 |
| 48 | Flattened epiphyses (HP:0003071) | 2.94708099 |
| 49 | Urticaria (HP:0001025) | 2.94547356 |
| 50 | Recurrent skin infections (HP:0001581) | 2.94329482 |
| 51 | Hypergammaglobulinemia (HP:0010702) | 2.83734645 |
| 52 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 2.80178145 |
| 53 | Exocrine pancreatic insufficiency (HP:0001738) | 2.78371836 |
| 54 | Chronic diarrhea (HP:0002028) | 2.75940766 |
| 55 | Ulnar bowing (HP:0003031) | 2.73515214 |
| 56 | Autoimmune hemolytic anemia (HP:0001890) | 2.70042803 |
| 57 | Leukopenia (HP:0001882) | 2.59592757 |
| 58 | Abnormality of T cell physiology (HP:0011840) | 2.56528339 |
| 59 | Abnormality of T cells (HP:0002843) | 2.55022609 |
| 60 | Dysostosis multiplex (HP:0000943) | 2.52228244 |
| 61 | Lymphoma (HP:0002665) | 2.51559564 |
| 62 | Spondylolisthesis (HP:0003302) | 2.47173430 |
| 63 | Irregular vertebral endplates (HP:0003301) | 2.46498824 |
| 64 | B lymphocytopenia (HP:0010976) | 2.44651233 |
| 65 | Abnormality of B cell number (HP:0010975) | 2.44651233 |
| 66 | Arthropathy (HP:0003040) | 2.43286458 |
| 67 | T lymphocytopenia (HP:0005403) | 2.38953112 |
| 68 | Pustule (HP:0200039) | 2.36776138 |
| 69 | Nasal polyposis (HP:0100582) | 2.35951204 |
| 70 | Thyroiditis (HP:0100646) | 2.32247777 |
| 71 | Encephalitis (HP:0002383) | 2.31667653 |
| 72 | Autoimmune thrombocytopenia (HP:0001973) | 2.30349545 |
| 73 | Granulocytopenia (HP:0001913) | 2.30344907 |
| 74 | Overlapping toe (HP:0001845) | 2.29394097 |
| 75 | IgG deficiency (HP:0004315) | 2.28005189 |
| 76 | Eczematoid dermatitis (HP:0000976) | 2.27066250 |
| 77 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.26160412 |
| 78 | Abnormality of T cell number (HP:0011839) | 2.25369039 |
| 79 | Hyperparathyroidism (HP:0000843) | 2.25135232 |
| 80 | Pulmonary infiltrates (HP:0002113) | 2.24416480 |
| 81 | Fatigue (HP:0012378) | 2.23073341 |
| 82 | Spastic paraparesis (HP:0002313) | 2.21898034 |
| 83 | Absent epiphyses (HP:0010577) | 2.21831945 |
| 84 | Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003) | 2.21831945 |
| 85 | Spontaneous hematomas (HP:0007420) | 2.21309421 |
| 86 | Papilledema (HP:0001085) | 2.19647019 |
| 87 | Skin ulcer (HP:0200042) | 2.18363912 |
| 88 | Thyroid-stimulating hormone excess (HP:0002925) | 2.17758176 |
| 89 | Nonimmune hydrops fetalis (HP:0001790) | 2.16423785 |
| 90 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.13246823 |
| 91 | Villous atrophy (HP:0011473) | 2.13246823 |
| 92 | Thrombocytosis (HP:0001894) | 2.13094780 |
| 93 | Resting tremor (HP:0002322) | 2.12148116 |
| 94 | Xerostomia (HP:0000217) | 2.11779774 |
| 95 | Gingival bleeding (HP:0000225) | 2.11494681 |
| 96 | Interstitial pulmonary disease (HP:0006530) | 2.09327457 |
| 97 | Skin rash (HP:0000988) | 2.08726600 |
| 98 | Limited elbow extension (HP:0001377) | 2.04871514 |
| 99 | Short middle phalanx of the 5th finger (HP:0004220) | 2.03059575 |
| 100 | Hematochezia (HP:0002573) | 2.03001126 |
| 101 | Arthralgia (HP:0002829) | 2.00797639 |
| 102 | Hepatitis (HP:0012115) | 2.00766829 |
| 103 | Macrocytic anemia (HP:0001972) | 2.00511664 |
| 104 | Abnormality of the thoracic spine (HP:0100711) | 2.00425623 |
| 105 | Loss of speech (HP:0002371) | 1.98112551 |
| 106 | Neoplasm of head and neck (HP:0012288) | 1.97323383 |
| 107 | Esophageal neoplasm (HP:0100751) | 1.97323383 |
| 108 | Deep palmar crease (HP:0006191) | 1.96899364 |
| 109 | Abnormality of glycolipid metabolism (HP:0010969) | 1.96725165 |
| 110 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.96725165 |
| 111 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.96725165 |
| 112 | Abnormality of the nasal mucosa (HP:0000433) | 1.95358135 |
| 113 | Large for gestational age (HP:0001520) | 1.94496453 |
| 114 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.93612819 |
| 115 | Facial diplegia (HP:0001349) | 1.93115814 |
| 116 | Global brain atrophy (HP:0002283) | 1.92786936 |
| 117 | Myocardial infarction (HP:0001658) | 1.92631553 |
| 118 | Chronic obstructive pulmonary disease (HP:0006510) | 1.91815061 |
| 119 | Obstructive lung disease (HP:0006536) | 1.91815061 |
| 120 | Neutropenia (HP:0001875) | 1.91724632 |
| 121 | Abnormality of the intervertebral disk (HP:0005108) | 1.91621634 |
| 122 | Acrocyanosis (HP:0001063) | 1.90880086 |
| 123 | Increased IgE level (HP:0003212) | 1.90270696 |
| 124 | Eosinophilia (HP:0001880) | 1.90266622 |
| 125 | Exercise-induced myalgia (HP:0003738) | 1.89778015 |
| 126 | Rhabdomyolysis (HP:0003201) | 1.89700828 |
| 127 | Syringomyelia (HP:0003396) | 1.88635023 |
| 128 | Spinal cord lesions (HP:0100561) | 1.88635023 |
| 129 | Malnutrition (HP:0004395) | 1.86421192 |
| 130 | Myositis (HP:0100614) | 1.86349078 |
| 131 | Easy fatigability (HP:0003388) | 1.85438930 |
| 132 | Severe combined immunodeficiency (HP:0004430) | 1.84407431 |
| 133 | Abnormality of the vertebral endplates (HP:0005106) | 1.84047315 |
| 134 | Gingivitis (HP:0000230) | 1.82397601 |
| 135 | Hyperthyroidism (HP:0000836) | 1.82152375 |
| 136 | Chest pain (HP:0100749) | 1.81764765 |
| 137 | Aortic regurgitation (HP:0001659) | 1.81553475 |
| 138 | Barrel-shaped chest (HP:0001552) | 1.77317709 |
| 139 | Basal cell carcinoma (HP:0002671) | 1.76117134 |
| 140 | Hypertensive crisis (HP:0100735) | 1.75808439 |
| 141 | Cubitus valgus (HP:0002967) | 1.73299617 |
| 142 | Periodontitis (HP:0000704) | 1.71214883 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TAOK3 | 7.16896146 |
| 2 | MAP4K1 | 6.98779232 |
| 3 | PIK3CG | 5.79706710 |
| 4 | GRK6 | 3.96917374 |
| 5 | MAP3K13 | 3.62440318 |
| 6 | PRPF4B | 3.23152948 |
| 7 | MAP3K10 | 2.86526873 |
| 8 | ERN1 | 2.84561868 |
| 9 | LRRK2 | 2.79753778 |
| 10 | CSF1R | 2.78264542 |
| 11 | RIPK4 | 2.69321645 |
| 12 | STK10 | 2.63429276 |
| 13 | MAP3K14 | 2.61771274 |
| 14 | BTK | 2.57724213 |
| 15 | SYK | 2.53524887 |
| 16 | BLK | 2.42676244 |
| 17 | SIK2 | 2.32353023 |
| 18 | TYK2 | 2.00666563 |
| 19 | CDK12 | 1.93158398 |
| 20 | TESK2 | 1.92377199 |
| 21 | GRK1 | 1.92212291 |
| 22 | JAK1 | 1.83953556 |
| 23 | SIK3 | 1.60039145 |
| 24 | ARAF | 1.59547029 |
| 25 | MARK3 | 1.55410825 |
| 26 | MST4 | 1.50831274 |
| 27 | LYN | 1.49155919 |
| 28 | IRAK3 | 1.46149928 |
| 29 | TGFBR2 | 1.45924970 |
| 30 | KIT | 1.39733635 |
| 31 | HCK | 1.31930679 |
| 32 | SIK1 | 1.30942949 |
| 33 | CSK | 1.28352607 |
| 34 | IKBKB | 1.22628058 |
| 35 | ITK | 1.21983782 |
| 36 | BRD4 | 1.21916037 |
| 37 | MAP3K9 | 1.13151783 |
| 38 | EEF2K | 1.11966632 |
| 39 | JAK3 | 1.11811342 |
| 40 | CDC42BPA | 1.09995858 |
| 41 | TEC | 1.08137434 |
| 42 | TBK1 | 1.07606072 |
| 43 | PRKD2 | 1.03913170 |
| 44 | CDK3 | 1.03759389 |
| 45 | IRAK4 | 1.01793672 |
| 46 | CCNB1 | 1.01293885 |
| 47 | EIF2AK3 | 1.00687358 |
| 48 | PRKCQ | 0.96889361 |
| 49 | CAMK1G | 0.96285529 |
| 50 | LCK | 0.95991851 |
| 51 | TNK2 | 0.92933563 |
| 52 | ZAP70 | 0.91054967 |
| 53 | CAMK1D | 0.90131456 |
| 54 | FES | 0.88120163 |
| 55 | PIM1 | 0.82250645 |
| 56 | ALK | 0.82049651 |
| 57 | CHUK | 0.80329333 |
| 58 | NEK9 | 0.76935613 |
| 59 | MAPK7 | 0.76595148 |
| 60 | MAP3K7 | 0.76348425 |
| 61 | FGFR3 | 0.75584894 |
| 62 | WNK1 | 0.74550918 |
| 63 | MATK | 0.73667298 |
| 64 | BRAF | 0.72832421 |
| 65 | MAPK12 | 0.72669206 |
| 66 | STK4 | 0.72386625 |
| 67 | PRKCH | 0.72369586 |
| 68 | HIPK2 | 0.71414943 |
| 69 | PDK1 | 0.67867418 |
| 70 | ABL1 | 0.66320519 |
| 71 | MAP2K3 | 0.66079404 |
| 72 | IKBKE | 0.64719940 |
| 73 | FGFR4 | 0.64385273 |
| 74 | KSR2 | 0.63946761 |
| 75 | CDK6 | 0.62224646 |
| 76 | BMPR2 | 0.59775561 |
| 77 | NME2 | 0.58119933 |
| 78 | CLK1 | 0.56202974 |
| 79 | MOS | 0.54955006 |
| 80 | RPS6KA4 | 0.54892619 |
| 81 | INSR | 0.54204974 |
| 82 | PRKD1 | 0.54178952 |
| 83 | TRIB3 | 0.50597821 |
| 84 | SCYL2 | 0.50344855 |
| 85 | FYN | 0.49955373 |
| 86 | EIF2AK1 | 0.49477077 |
| 87 | MAP3K11 | 0.45485896 |
| 88 | TTN | 0.44320290 |
| 89 | CSNK1A1L | 0.44105963 |
| 90 | RAF1 | 0.44037807 |
| 91 | SGK3 | 0.43737388 |
| 92 | RPS6KB2 | 0.43649303 |
| 93 | CDK9 | 0.43449070 |
| 94 | PTK6 | 0.43119063 |
| 95 | FGR | 0.42357019 |
| 96 | CDK4 | 0.42324044 |
| 97 | MAPK11 | 0.42164287 |
| 98 | MAP3K1 | 0.42082415 |
| 99 | TXK | 0.41953974 |
| 100 | RPS6KC1 | 0.39183471 |
| 101 | RPS6KL1 | 0.39183471 |
| 102 | MARK2 | 0.38896366 |
| 103 | DYRK1B | 0.37950435 |
| 104 | EPHB1 | 0.37159507 |
| 105 | EGFR | 0.34109671 |
| 106 | JAK2 | 0.33258890 |
| 107 | STK24 | 0.32303536 |
| 108 | CDK8 | 0.31963596 |
| 109 | PIM2 | 0.31505490 |
| 110 | MELK | 0.31274936 |
| 111 | PAK4 | 0.30678102 |
| 112 | RPS6KA6 | 0.28864392 |
| 113 | STK11 | 0.27183077 |
| 114 | CHEK1 | 0.26213332 |
| 115 | MAPK4 | 0.25630232 |
| 116 | PRKCD | 0.25207905 |
| 117 | PKN2 | 0.24409251 |
| 118 | MAP3K8 | 0.24396929 |
| 119 | SRPK1 | 0.23124155 |
| 120 | PDPK1 | 0.23044768 |
| 121 | MAP2K1 | 0.22905540 |
| 122 | TAOK2 | 0.20689056 |
| 123 | SMG1 | 0.20560852 |
| 124 | CSNK1G1 | 0.19880668 |
| 125 | MAPK3 | 0.18762135 |
| 126 | ROCK2 | 0.18659215 |
| 127 | MAP2K2 | 0.17968970 |
| 128 | SGK2 | 0.17451284 |
| 129 | CSNK1D | 0.17216327 |
| 130 | YES1 | 0.16426360 |
| 131 | DYRK1A | 0.16420642 |
| 132 | TNIK | 0.16145048 |
| 133 | SRC | 0.15430398 |
| 134 | NLK | 0.14087850 |
| 135 | CSNK1G3 | 0.13919899 |
| 136 | NEK2 | 0.13782690 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 6.83387600 |
| 2 | Primary immunodeficiency_Homo sapiens_hsa05340 | 6.27222177 |
| 3 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 4.11638793 |
| 4 | Protein export_Homo sapiens_hsa03060 | 3.65308309 |
| 5 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 3.55788579 |
| 6 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 3.54010737 |
| 7 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.07826116 |
| 8 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.95859491 |
| 9 | Allograft rejection_Homo sapiens_hsa05330 | 2.73343043 |
| 10 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.44678087 |
| 11 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.34347609 |
| 12 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.22439185 |
| 13 | Asthma_Homo sapiens_hsa05310 | 2.19579559 |
| 14 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.19474409 |
| 15 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 2.13512653 |
| 16 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.10366970 |
| 17 | Other glycan degradation_Homo sapiens_hsa00511 | 2.05692616 |
| 18 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.97753169 |
| 19 | Leishmaniasis_Homo sapiens_hsa05140 | 1.94522062 |
| 20 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.90945575 |
| 21 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.86626615 |
| 22 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.74902342 |
| 23 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.71896655 |
| 24 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.66463159 |
| 25 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.65554656 |
| 26 | Tuberculosis_Homo sapiens_hsa05152 | 1.50832943 |
| 27 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.43469525 |
| 28 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.42139546 |
| 29 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.39344048 |
| 30 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.39158167 |
| 31 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.38959305 |
| 32 | Platelet activation_Homo sapiens_hsa04611 | 1.33398106 |
| 33 | Measles_Homo sapiens_hsa05162 | 1.33133511 |
| 34 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.32820280 |
| 35 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.30996834 |
| 36 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.21660154 |
| 37 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.20976380 |
| 38 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.16465914 |
| 39 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.10142326 |
| 40 | Shigellosis_Homo sapiens_hsa05131 | 1.07762616 |
| 41 | Influenza A_Homo sapiens_hsa05164 | 1.05821801 |
| 42 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.05472430 |
| 43 | Hepatitis B_Homo sapiens_hsa05161 | 1.04671507 |
| 44 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.04663979 |
| 45 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.04469849 |
| 46 | Lysine degradation_Homo sapiens_hsa00310 | 1.01272245 |
| 47 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.97845743 |
| 48 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.97520034 |
| 49 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.92056126 |
| 50 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.90062283 |
| 51 | Endometrial cancer_Homo sapiens_hsa05213 | 0.88911183 |
| 52 | Apoptosis_Homo sapiens_hsa04210 | 0.88660327 |
| 53 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.86801472 |
| 54 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.85531788 |
| 55 | Viral myocarditis_Homo sapiens_hsa05416 | 0.83176477 |
| 56 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.82948548 |
| 57 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.82262922 |
| 58 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.81787900 |
| 59 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.79363838 |
| 60 | Hepatitis C_Homo sapiens_hsa05160 | 0.78569447 |
| 61 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.77074738 |
| 62 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.73210100 |
| 63 | Insulin resistance_Homo sapiens_hsa04931 | 0.69253716 |
| 64 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.68973076 |
| 65 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.68902959 |
| 66 | Lysosome_Homo sapiens_hsa04142 | 0.68504367 |
| 67 | Base excision repair_Homo sapiens_hsa03410 | 0.67621365 |
| 68 | HTLV-I infection_Homo sapiens_hsa05166 | 0.66870671 |
| 69 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.65146556 |
| 70 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.64295125 |
| 71 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.63208228 |
| 72 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.63189769 |
| 73 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.62825364 |
| 74 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.60737968 |
| 75 | Malaria_Homo sapiens_hsa05144 | 0.59858140 |
| 76 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.59579091 |
| 77 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.58092423 |
| 78 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.57223709 |
| 79 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.55587544 |
| 80 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.55336411 |
| 81 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.55283018 |
| 82 | Endocytosis_Homo sapiens_hsa04144 | 0.55171323 |
| 83 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.54458610 |
| 84 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.53801842 |
| 85 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.53702214 |
| 86 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.53281047 |
| 87 | Pertussis_Homo sapiens_hsa05133 | 0.51253874 |
| 88 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.50369874 |
| 89 | Salmonella infection_Homo sapiens_hsa05132 | 0.49667803 |
| 90 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.49230594 |
| 91 | Phagosome_Homo sapiens_hsa04145 | 0.48607707 |
| 92 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.48098779 |
| 93 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.47827159 |
| 94 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.47614932 |
| 95 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.46554243 |
| 96 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.46503786 |
| 97 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.45769952 |
| 98 | Long-term potentiation_Homo sapiens_hsa04720 | 0.45721316 |
| 99 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.44793239 |
| 100 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.44361058 |
| 101 | Glioma_Homo sapiens_hsa05214 | 0.43797658 |
| 102 | Colorectal cancer_Homo sapiens_hsa05210 | 0.43785332 |
| 103 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.42788847 |
| 104 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.42449532 |
| 105 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.38954493 |
| 106 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.38216066 |
| 107 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.37756584 |
| 108 | Prostate cancer_Homo sapiens_hsa05215 | 0.36986658 |
| 109 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.36698720 |
| 110 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.35408459 |
| 111 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.34773560 |
| 112 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.34093518 |
| 113 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.31916142 |
| 114 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.31805517 |
| 115 | Legionellosis_Homo sapiens_hsa05134 | 0.31711474 |
| 116 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.31512947 |
| 117 | Ribosome_Homo sapiens_hsa03010 | 0.31003183 |
| 118 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.30157442 |
| 119 | Bladder cancer_Homo sapiens_hsa05219 | 0.27968850 |
| 120 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.27310127 |
| 121 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.26656865 |
| 122 | Pathways in cancer_Homo sapiens_hsa05200 | 0.26641279 |
| 123 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.26340342 |
| 124 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.26277184 |
| 125 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.25788440 |
| 126 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.25132888 |
| 127 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.24647311 |
| 128 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.23821330 |
| 129 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.23571269 |
| 130 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.23264689 |
| 131 | Renin secretion_Homo sapiens_hsa04924 | 0.23194096 |
| 132 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.22866302 |
| 133 | ABC transporters_Homo sapiens_hsa02010 | 0.21468653 |
| 134 | Spliceosome_Homo sapiens_hsa03040 | 0.21415590 |

